Tom Miller, Iambic Therapeutics CEO
Iambic attempts to ‘break the wall’ between the lab and clinic with new AI model
Iambic Therapeutics has used its AI models to build a pipeline and put its first drug candidate in the clinic earlier this year. Now, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
